United States Human Coagulation Factor VIII Market Report 2017

January 2017 | 101 pages | ID: UE976F5B016EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Human Coagulation Factor VIII

Revenue, means the sales value of Human Coagulation Factor VIII

This report studies sales (consumption) of Human Coagulation Factor VIII in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Baxter
• Bayer
• Pfizer
• CSL Behring
• Grifols
• Octapharma
• BPL
• Kedrion

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Recombinant Factor VIII
• Plasma-derived Factor VIII

Split by applications, this report focuses on sales, market share and growth rate of Human Coagulation Factor VIII in each application, can be divided into

• Hemophilia A
• Spontanous + Traum
• Surgical

Contents

United States Human Coagulation Factor VIII Market Report 2017

1 HUMAN COAGULATION FACTOR VIII OVERVIEW

1.1 Product Overview and Scope of Human Coagulation Factor VIII
1.2 Classification of Human Coagulation Factor VIII
  1.2.1 Recombinant Factor VIII
  1.2.2 Plasma-derived Factor VIII
1.3 Application of Human Coagulation Factor VIII
  1.3.1 Hemophilia A
  1.3.2 Spontanous + Traum
  1.3.3 Surgical
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Human Coagulation Factor VIII (2011-2021)
  1.4.1 United States Human Coagulation Factor VIII Sales and Growth Rate (2011-2021)
  1.4.2 United States Human Coagulation Factor VIII Revenue and Growth Rate (2011-2021)

2 UNITED STATES HUMAN COAGULATION FACTOR VIII COMPETITION BY MANUFACTURERS

2.1 United States Human Coagulation Factor VIII Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Human Coagulation Factor VIII Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Human Coagulation Factor VIII Average Price by Manufactures (2015 and 2016)
2.4 Human Coagulation Factor VIII Market Competitive Situation and Trends
  2.4.1 Human Coagulation Factor VIII Market Concentration Rate
  2.4.2 Human Coagulation Factor VIII Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES HUMAN COAGULATION FACTOR VIII SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Human Coagulation Factor VIII Sales and Market Share by States (2011-2016)
3.2 United States Human Coagulation Factor VIII Revenue and Market Share by States (2011-2016)
3.3 United States Human Coagulation Factor VIII Price by States (2011-2016)

4 UNITED STATES HUMAN COAGULATION FACTOR VIII SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Human Coagulation Factor VIII Sales and Market Share by Type (2011-2016)
4.2 United States Human Coagulation Factor VIII Revenue and Market Share by Type (2011-2016)
4.3 United States Human Coagulation Factor VIII Price by Type (2011-2016)
4.4 United States Human Coagulation Factor VIII Sales Growth Rate by Type (2011-2016)

5 UNITED STATES HUMAN COAGULATION FACTOR VIII SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Human Coagulation Factor VIII Sales and Market Share by Application (2011-2016)
5.2 United States Human Coagulation Factor VIII Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES HUMAN COAGULATION FACTOR VIII MANUFACTURERS PROFILES/ANALYSIS

6.1 Baxter
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Human Coagulation Factor VIII Product Type, Application and Specification
    6.1.2.1 Recombinant Factor VIII
    6.1.2.2 Plasma-derived Factor VIII
  6.1.3 Baxter Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Bayer
  6.2.2 Human Coagulation Factor VIII Product Type, Application and Specification
    6.2.2.1 Recombinant Factor VIII
    6.2.2.2 Plasma-derived Factor VIII
  6.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 Pfizer
  6.3.2 Human Coagulation Factor VIII Product Type, Application and Specification
    6.3.2.1 Recombinant Factor VIII
    6.3.2.2 Plasma-derived Factor VIII
  6.3.3 Pfizer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 CSL Behring
  6.4.2 Human Coagulation Factor VIII Product Type, Application and Specification
    6.4.2.1 Recombinant Factor VIII
    6.4.2.2 Plasma-derived Factor VIII
  6.4.3 CSL Behring Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Grifols
  6.5.2 Human Coagulation Factor VIII Product Type, Application and Specification
    6.5.2.1 Recombinant Factor VIII
    6.5.2.2 Plasma-derived Factor VIII
  6.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Octapharma
  6.6.2 Human Coagulation Factor VIII Product Type, Application and Specification
    6.6.2.1 Recombinant Factor VIII
    6.6.2.2 Plasma-derived Factor VIII
  6.6.3 Octapharma Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 BPL
  6.7.2 Human Coagulation Factor VIII Product Type, Application and Specification
    6.7.2.1 Recombinant Factor VIII
    6.7.2.2 Plasma-derived Factor VIII
  6.7.3 BPL Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 Kedrion
  6.8.2 Human Coagulation Factor VIII Product Type, Application and Specification
    6.8.2.1 Recombinant Factor VIII
    6.8.2.2 Plasma-derived Factor VIII
  6.8.3 Kedrion Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview

7 HUMAN COAGULATION FACTOR VIII MANUFACTURING COST ANALYSIS

7.1 Human Coagulation Factor VIII Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Human Coagulation Factor VIII

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Human Coagulation Factor VIII Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Human Coagulation Factor VIII Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HUMAN COAGULATION FACTOR VIII MARKET FORECAST (2016-2021)

11.1 United States Human Coagulation Factor VIII Sales, Revenue Forecast (2016-2021)
11.2 United States Human Coagulation Factor VIII Sales Forecast by Type (2016-2021)
11.3 United States Human Coagulation Factor VIII Sales Forecast by Application (2016-2021)
11.4 Human Coagulation Factor VIII Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Human Coagulation Factor VIII
Table Classification of Human Coagulation Factor VIII
Figure United States Sales Market Share of Human Coagulation Factor VIII by Type in 2015
Figure Recombinant Factor VIII Picture
Figure Plasma-derived Factor VIII Picture
Table Application of Human Coagulation Factor VIII
Figure United States Sales Market Share of Human Coagulation Factor VIII by Application in 2015
Figure Hemophilia A Examples
Figure Spontanous + Traum Examples
Figure Surgical Examples
Figure United States Human Coagulation Factor VIII Sales and Growth Rate (2011-2021)
Figure United States Human Coagulation Factor VIII Revenue and Growth Rate (2011-2021)
Table United States Human Coagulation Factor VIII Sales of Key Manufacturers (2015 and 2016)
Table United States Human Coagulation Factor VIII Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Human Coagulation Factor VIII Sales Share by Manufacturers
Figure 2016 Human Coagulation Factor VIII Sales Share by Manufacturers
Table United States Human Coagulation Factor VIII Revenue by Manufacturers (2015 and 2016)
Table United States Human Coagulation Factor VIII Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Human Coagulation Factor VIII Revenue Share by Manufacturers
Table 2016 United States Human Coagulation Factor VIII Revenue Share by Manufacturers
Table United States Market Human Coagulation Factor VIII Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Human Coagulation Factor VIII Average Price of Key Manufacturers in 2015
Figure Human Coagulation Factor VIII Market Share of Top 3 Manufacturers
Figure Human Coagulation Factor VIII Market Share of Top 5 Manufacturers
Table United States Human Coagulation Factor VIII Sales by States (2011-2016)
Table United States Human Coagulation Factor VIII Sales Share by States (2011-2016)
Figure United States Human Coagulation Factor VIII Sales Market Share by States in 2015
Table United States Human Coagulation Factor VIII Revenue and Market Share by States (2011-2016)
Table United States Human Coagulation Factor VIII Revenue Share by States (2011-2016)
Figure Revenue Market Share of Human Coagulation Factor VIII by States (2011-2016)
Table United States Human Coagulation Factor VIII Price by States (2011-2016)
Table United States Human Coagulation Factor VIII Sales by Type (2011-2016)
Table United States Human Coagulation Factor VIII Sales Share by Type (2011-2016)
Figure United States Human Coagulation Factor VIII Sales Market Share by Type in 2015
Table United States Human Coagulation Factor VIII Revenue and Market Share by Type (2011-2016)
Table United States Human Coagulation Factor VIII Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Human Coagulation Factor VIII by Type (2011-2016)
Table United States Human Coagulation Factor VIII Price by Type (2011-2016)
Figure United States Human Coagulation Factor VIII Sales Growth Rate by Type (2011-2016)
Table United States Human Coagulation Factor VIII Sales by Application (2011-2016)
Table United States Human Coagulation Factor VIII Sales Market Share by Application (2011-2016)
Figure United States Human Coagulation Factor VIII Sales Market Share by Application in 2015
Table United States Human Coagulation Factor VIII Sales Growth Rate by Application (2011-2016)
Figure United States Human Coagulation Factor VIII Sales Growth Rate by Application (2011-2016)
Table Baxter Basic Information List
Table Baxter Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Baxter Human Coagulation Factor VIII Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Human Coagulation Factor VIII Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Human Coagulation Factor VIII Sales Market Share (2011-2016)
Table CSL Behring Basic Information List
Table CSL Behring Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table CSL Behring Human Coagulation Factor VIII Sales Market Share (2011-2016)
Table Grifols Basic Information List
Table Grifols Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Grifols Human Coagulation Factor VIII Sales Market Share (2011-2016)
Table Octapharma Basic Information List
Table Octapharma Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Octapharma Human Coagulation Factor VIII Sales Market Share (2011-2016)
Table BPL Basic Information List
Table BPL Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table BPL Human Coagulation Factor VIII Sales Market Share (2011-2016)
Table Kedrion Basic Information List
Table Kedrion Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kedrion Human Coagulation Factor VIII Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Coagulation Factor VIII
Figure Manufacturing Process Analysis of Human Coagulation Factor VIII
Figure Human Coagulation Factor VIII Industrial Chain Analysis
Table Raw Materials Sources of Human Coagulation Factor VIII Major Manufacturers in 2015
Table Major Buyers of Human Coagulation Factor VIII
Table Distributors/Traders List
Figure United States Human Coagulation Factor VIII Production and Growth Rate Forecast (2016-2021)
Figure United States Human Coagulation Factor VIII Revenue and Growth Rate Forecast (2016-2021)
Table United States Human Coagulation Factor VIII Production Forecast by Type (2016-2021)
Table United States Human Coagulation Factor VIII Consumption Forecast by Application (2016-2021)
Table United States Human Coagulation Factor VIII Sales Forecast by States (2016-2021)
Table United States Human Coagulation Factor VIII Sales Share Forecast by States (2016-2021)